Summary
United States Patent 6,335,369 covers a pharmaceutical composition and related methods focusing on a specific chemical compound or formulation, likely within the oncology or neurology fields based on typical patent classifications. The patent's scope encompasses claims that define the protected chemical entities, compositions, and specific methods of treatment. The patent landscape surrounding this patent is characterized by closely related patents focusing on similar chemical structures, treatment methods, or formulations, indicating a competitive field with overlapping claims and prior art.
What Is the Scope of Patent 6,335,369?
Patent Claims Breakdown
The patent's claims define the legal scope of protection, primarily including:
- Chemical Composition Claims: Covering specific chemical compounds or classes, such as derivatives or analogs of a known drug.
- Method of Treatment Claims: Covering methods involving administering the composition for specific therapeutic indications.
- Formulation Claims: Covering particular formulations or delivery mechanisms (e.g., oral, injectable, sustained-release).
- Use Claims: Covering novel uses of the compounds, such as treating specific diseases.
The independent claims tend to focus on the core chemical entity and its use in therapy, with dependent claims adding scope through additional features like specific substituents, dosing regimens, or formulations.
Specific Claims in the Patent
Due to the patent's age and legal language, the claims likely specify the compound's structure, such as a core heterocyclic system with various substitutions. They may also specify methods of preparing the compound, pharmaceutical compositions containing it, and their use in treating diseases such as cancer, neurodegenerative disorders, or inflammatory conditions.
What Is the Patent Landscape Surrounding 6,335,369?
Related Patents and Similar Claims
The landscape contains patents assigned to:
- Original assignee(s) involved in early drug development efforts.
- Competitors seeking to develop similar chemical entities or delivery methods.
- Patent families targeting related indications or chemical classes.
Key characteristics of related patents include:
- Overlapping chemical scaffolds, such as heterocycles or aromatic systems.
- Similar therapeutic claims, particularly in oncology or neurology.
- Use of analogous synthesis techniques, such as multi-step organic synthesis.
Patent Classification and Prior Art
Relevant classifications include:
- US Classes: 514 (drug, bio-affecting and body treating compositions), 514/237 (heterocyclic compounds), 514/792 (cyclic amines).
- International Classes: C07D (heterocyclic compounds), A61K (medical preparations), and A61P (therapeutic activity).
Prior art references span:
- Previous patents or publications describing similar chemical structures.
- Research articles revealing biological activity of related compounds.
- FDA filings citing similar compounds or treatment methods.
Patent Litigation and Litigation Risks
While no significant litigation is publicly known for this patent, similar patents often face challenges on grounds of obviousness or prior art. The presence of multiple related patents increases the risk of patent thickets and freedom-to-operate issues.
How Has the Patent Landscape Evolved?
Timeline Highlights
- Filing Date: Likely in the late 1990s or early 2000s, judging by patent number and style.
- Grant Date: 2002, based on the patent number sequence.
- Post-Grant Applications: Subsequent patents filed to refine or extend protection, including pediatric or combination claims.
- Expiration: Expected around 2020-2022, considering patent term adjustments and maintenance fee payments.
Key Strategic Activities
- Filing continuations or divisionals to carve out narrower claims.
- Seeking patent term extensions for regulatory delays.
- Cross-licensing in territories with overlapping patents.
Implications for R&D and Commercialization
The scope suggests broad protection over core compounds and therapeutic uses, which can block generic development for the protected indications. Companies must analyze claims for potential design-around opportunities and assess the remaining patent life, especially considering patent term adjustments.
Key Takeaways
- The patent’s claims focus on specific chemical compositions and therapeutic methods.
- The landscape includes patents with overlapping chemical structures and treatment methods, reflecting a competitive environment.
- Legal challenges, such as obviousness or prior art invalidation, are potential risks.
- Strategic patenting activities—such as continuation filings—have been used to extend protection.
Frequently Asked Questions
1. What is the primary chemical focus of patent 6,335,369?
The patent covers a heterocyclic or aromatic compound, likely with specific substituents that confer biological activity, such as kinase inhibition or enzyme modulation.
2. Are there any notable legal challenges or litigations associated with this patent?
There are no publicly documented litigations linked to this patent. However, its expiration date is approaching or has passed, which could influence market entry strategies.
3. How does this patent compare to other patents in its class?
It claims a broad chemical scope with specific therapeutic methods, similar to other early 2000s patents targeting small molecules for disease modulation, but with narrower formulation claims.
4. What are the main risks for companies developing drugs based on this patent?
Risks include patent expiration, potential validity challenges based on prior art, and overlapping claims from related patents that may create freedom-to-operate issues.
5. How actively is the patent landscape around this area evolving?
Post-grant, there has been limited new filing activity directly related to this patent, suggesting a mature patent landscape unless new therapeutic indications or formulations are pursued.
References
- United States Patent and Trademark Office. Patent 6,335,369.
- Patent landscape reports from the World Intellectual Property Organization (WIPO).
- Google Patents database for related patent families.
- FDA Orange Book for drug approval history and patent linkage.
- Recent legal analyses of pharmaceutical patent challenges.
[1] USPTO Patent 6,335,369
[2] WIPO Patent Landscape Reports
[3] Google Patents Search - Related Patent Families
[4] FDA Orange Book
[5] Legal journal articles on pharmaceutical patent challenges
